IBM (IBM)

Investing Cash Flow

-$9.99B

TTM · Period ending: · USD

IBM logo

IBM Investing Cash Flow

Latest reported-$9.99B
IBM TTM Cash from Investing (-$7.14B → -$9.99B)
High-resolution chart · PNG

IBM investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

IBM Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-9,991,000,000
-7,812,000,000
-10,302,000,000
-13,098,000,000
-14,247,000,000
-13,706,000,000
-4,937,000,000
-722,000,000
-1,088,000,000
-3,320,000,000
-7,070,000,000
-11,225,000,000
-10,969,000,000
-10,804,000,000
-4,202,000,000
-3,558,000,000
-2,490,000,000
-5,333,000,000
-5,975,000,000
-5,858,000,000
-5,561,000,000
-4,126,000,000
-3,028,000,000
-2,343,000,000
-32,384,000,000
-26,986,000,000
-26,937,000,000
-26,609,000,000
795,000,000
-4,001,000,000
-4,912,000,000
-9,185,000,000
-8,139,000,000
-9,210,000,000
-7,096,000,000
-6,214,000,000
-5,341,000,000
-8,158,000,000
-10,508,000,000
-12,972,000,000
-13,222,000,000
-10,600,000,000
-8,000,000,000
-3,800,000,000
-3,300,000,000
-2,400,000,000
-2,965,000,000
-4,665,000,000
-6,365,000,000
-6,265,000,000
-7,300,000,000
-8,500,000,000
-7,000,000,000
-7,783,000,000
-9,013,000,000
-8,418,000,000
-8,223,000,000
-7,140,000,000
-4,412,000,000
-4,989,000,000
-5,964,000,000
-7,310,000,000
-8,507,000,000
-6,920,000,000
-7,477,000,000
-7,380,000,000
-6,729,000,000
-5,114,000,000
-4,273,000,000
-3,555,000,000
-9,285,000,000
-7,307,000,000
-9,015,000,000
-8,035,000,000
-4,675,000,000
-11,406,000,000
-9,147,000,000
-9,959,000,000
-11,549,000,000
-7,347,000,000
-7,376,000,000
-7,751,000,000
-4,423,000,000
-4,619,000,000
-4,725,000,000
-4,319,000,000
-5,346,000,000
-4,325,000,000
-4,453,000,000
-4,154,000,000
-5,122,000,000
-8,109,000,000
-7,687,000,000
-8,115,000,000
-6,897,000,000
-4,309,000,000
-5,950,000,000
-6,181,000,000
-6,106,000,000
-6,927,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.